Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25


Effect of assisted walking-movement in patients with genetic and acquired neuromuscular disorders with the motorised Innowalk device: an international case study meta-analysis.

Schmidt-Lucke C, Käferle J, Rydh Berner BM, Ahlborg L, Hansen HM, Skjellvik Tollefsen U, Thon T, Damkjær Moen R, Pekanovic A, Tornberg ÅB, Lauruschkus K.

PeerJ. 2019 Jun 18;7:e7098. doi: 10.7717/peerj.7098. eCollection 2019.


Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.

Zobel T, Bock CT, Kühl U, Rohde M, Lassner D, Schultheiss HP, Schmidt-Lucke C.

Viruses. 2019 Mar 6;11(3). pii: E227. doi: 10.3390/v11030227.


Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy.

Schmidt-Lucke C, Zobel T, Escher F, Tschöpe C, Lassner D, Kühl U, Gubbe K, Volk HD, Schultheiss HP.

J Infect Dis. 2018 Jan 17;217(3):456-465. doi: 10.1093/infdis/jix309.


Persistent weight loss with a non-invasive novel medical device to change eating behaviour in obese individuals with high-risk cardiovascular risk profile.

von Seck P, Sander FM, Lanzendorf L, von Seck S, Schmidt-Lucke A, Zielonka M, Schmidt-Lucke C.

PLoS One. 2017 Apr 12;12(4):e0174528. doi: 10.1371/journal.pone.0174528. eCollection 2017.


Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy.

Schmidt-Lucke C, Escher F, Van Linthout S, Kühl U, Miteva K, Ringe J, Zobel T, Schultheiss HP, Tschöpe C.

Mediators Inflamm. 2015;2015:308185. doi: 10.1155/2015/308185. Epub 2015 Feb 28.


Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.

Schmidt-Lucke C, Zobel T, Schrepfer S, Kuhl U, Wang D, Klingel K, Becher PM, Fechner H, Pozzuto T, Van Linthout S, Lassner D, Spillmann F, Escher F, Holinski S, Volk HD, Schultheiss HP, Tschope C.

J Infect Dis. 2015 Oct 1;212(7):1070-81. doi: 10.1093/infdis/jiv178. Epub 2015 Mar 24.


Platelet activation and thrombus formation relates to the presence of myocardial inflammation in patients with cardiomyopathy.

Bobbert P, Weikert U, Schmidt-Lucke C, Skurk C, Meyer A, Steffens D, Schultheiss HP, Rauch U.

J Cardiol. 2014 May;63(5):379-84. doi: 10.1016/j.jjcc.2013.09.014. Epub 2013 Nov 11.


Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.

Pozzuto T, von Kietzell K, Bock T, Schmidt-Lucke C, Poller W, Zobel T, Lassner D, Zeichhardt H, Weger S, Fechner H.

Virology. 2011 Mar 1;411(1):50-64. doi: 10.1016/j.virol.2010.12.019. Epub 2011 Jan 13.


Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.

Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschöpe C, Schultheiss HP, Zeiher AM, Dimmeler S.

PLoS One. 2010 Nov 3;5(11):e13790. doi: 10.1371/journal.pone.0013790.


Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis.

Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S, Zeiher AM, de Kreutzenberg S, Avogaro A, Nickenig G, Schmidt-Lucke C, Werner N.

PLoS One. 2010 Jul 9;5(7):e11488. doi: 10.1371/journal.pone.0011488.


Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy.

Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S.

Atherosclerosis. 2010 Jul;211(1):249-54. doi: 10.1016/j.atherosclerosis.2010.02.007. Epub 2010 Feb 13.


Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.

Schmidt-Lucke C, Spillmann F, Bock T, Kühl U, Van Linthout S, Schultheiss HP, Tschöpe C.

J Infect Dis. 2010 Mar 15;201(6):936-45. doi: 10.1086/650700.


Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.

Schädlich PK, Schmidt-Lucke C, Huppertz E, Lehmacher W, Nixdorff U, Stellbrink C, Brecht JG.

Am J Cardiovasc Drugs. 2007;7(3):199-217.


Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome.

Schmidt-Lucke C, Schultheiss HP.

Vasc Health Risk Manag. 2007;3(2):221-8. Review.


Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients.

Schmidt-Lucke C, Aicher A, Romagnani P, Gareis B, Romagnani S, Zeiher AM, Dimmeler S.

Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2425-31. Epub 2007 Jan 19.


Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.

Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, Schmidt-Lucke C, Kusus M, Maas R, Schwedhelm E, Strödter D, Simon BC, Mügge A, Daniel WG, Tillmanns H, Maisch B, Streichert T, Böger RH.

Am Heart J. 2006 Sep;152(3):493.e1-8.


Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.

Fichtlscherer S, Schmidt-Lucke C, Bojunga S, Rössig L, Heeschen C, Dimmeler S, Zeiher AM.

Eur Heart J. 2006 May;27(10):1182-90. Epub 2006 Apr 18.


Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.

Taneva E, Borucki K, Wiens L, Makarova R, Schmidt-Lucke C, Luley C, Westphal S.

Am J Cardiol. 2006 Apr 1;97(7):1002-6. Epub 2006 Feb 13.


Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.

Schmidt-Lucke C, Paar WD, Stellbrink C, Nixdorff U, Hofmann T, Meurer J, Grewe R, Daniel WG, Hanrath P, Mügge A, Klein HU, Schmidt-Lucke JA.

Thromb Res. 2007;119(1):27-34. Epub 2006 Jan 27.


Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.

Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM.

Circulation. 2005 Jun 7;111(22):2981-7. Epub 2005 May 31.


Supplemental Content

Loading ...
Support Center